Ekspresi Cyclooxygenase-2 (COX-2) Pada Penderita Karsinoma Nasofaring Dengan Pemberian Kemoradioterapi Konkuren
DAFTAR PUSTAKA
Adham, M, Kurniawan, AN, Muhtadi, AI, Roezin, A, Hermani, B, carcinoma in Indonesia: epidemiology, incidence, signs and symptoms at presentation’ Chinese Journal of cancer, vol. 31, no. 4, pp. 185 - 96.
Agulnik M., Siu LL. 2005. ‘State-of-the-art management of nasopharyngeal carcinoma: current and future directions’. Brit J Cancer (92) :pp.799- 806. Andrianto, Y 2008, Peranan Pemeriksaan Immunohistokimia COX-2 pada
Karsinoma Nasofaring, Tesis, Bagian Patologi Anatomi Fakultas
Kedokteran Universitas Sumatera Utara, Medan.Baehaqi, R 2012, Hubungan Antara Jumlah Leukosit, Dan Skor Karnofsky
pada Pasien Kanker Paru, Karya Tulis Ilmiah, Program Pendidikan Sarjana Kedokteran Fakultas Kedokteran Universitas Diponegoro.
Semarang. Brennan, B 2006, ‘Nasopharyngeal Carcinoma’, Orphanet Journal of Rare Diseases, Vol. 1, no. 23, pp. 1 - 5.
Borek, C 2004, ‘Antioxidant and radiation therapy’, Nutrition J, Vol. 134, pp.
3207-3209. Candelaria, M, Arias, AG, Cetina, L & Gonzales, AD 2006,
‘Radiosensitizers in cervical cancer. cisplatin and beyond’, Radition Oncology, Vol. 1, no. 15, pp. 1-17. Cervello, MD, Fodera, AM, Florena, M, Soresi, C, Tripodo, ND, Alessandro & Montalto, G 2005, ‘Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human and angiogenesis’, World J. Gastroenterol, vol. 11, no.30, pp.4638-43.
Chen, QY, Wen, YF, Guo, L, Liu, H, Huang, PY, Mo, HY, Li, NW, Xiang, YQ, Luo, DH, Qiu, F, Sun, R, Deng, MQ, Chen, MY, Hua, YJ, Guo, X, Lao, KJ, Hong, MH, Qian, CN & Mai, HQ 2011, ‘Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: Phase III randomized trial’, J Natl Cancer Inst, vol. 103, pp.1-10.
Chew, CT 1997, Nasopharynx (the post nasal space), in Kerr AG (ed),
th
Scott-Brown’s Otolaryngology, Vol. 5, 6 edn, Butterworth Heinemann, Oxford.
Choy, H & Milas, L 2003, ‘Enhancing Radiotherapy with Cyclooxygenase-2 Enzym Inhibitors: A Rational Advance?’, Journal of the National Cancer Institute, Vol. 95, no. 19, pp. 1440-1452.
Cummings, CW, Fredrickson, JM, & Harker, LA 2005, Nasopharyngeal
Carcinoma, Cummings Otolaryngology Head and Neck Surgery 4th edition, USA, Mosby.
Ekawati, K & Handayani, L 2012, Perbandingan Kelangsungan Hidup
antara Penderita Locally Advanced Cervical Cancer yang Mendapatkan Kemoradioterapi dengan Radioterapi di Instalasi Radioterapi RSUD Dr. Soetomo Surabaya, Artikel Ilmiah. Fakultas Kedokteran / Departemen Radiologi Universitas Airlangga, Surabaya. Firdaus, MA & Prijadi, J 2009, Kemoterapi Neoadjuvan pada Karsinoma
Nasofaring, Bagian Telinga Hidung Tenggorok Bedah Kepala Leher
Fakultas Kedokteran Universitas Andalas/RSUP Dr. M. Djamil, Gallo, O, Franchi, A, Magnelli, L, Sardi, I, Vannacci, A, Boddi, V, Chiarugi,
V & Marsini, E 2001, ‘Cyclooxygenase-2 Pathway Correlates with
VEGF Expression in Head and Neck Cancer. Implications for Tumor Angiogenesis and Metastasis’, Neoplasia, Vol. 3, no. 1, pp. 53 - 61.
Gandamihardja, S, Firman, F, Wirakusumah, Shahib, N,Sastramihardja, HS, Aziz, F 2010, ‘Peran Siklooksigenase dalam Pertumbuhan Kanker Leher Rahim’, Departemen Obstetri dan Ginekologi, Departemen Biokimia, Departemen Farmakologi Klinik Fakultas Kedokteran Universitas Padjdjaran, Bagian Obsteri dan Ginekologi Klinik Universitas Indonesia. MKB, vol. 42, no. 4, pp.169-74.
Gao, J, Hu, JY, Xia, YF, Tao, YL & Li, G 2009, ‘Continuous fall in hemoglobin level is a poor prognostic factor in patients with nasopharyngeal carcinoma treated with radiotherapy’, Chinese Journal of Cancer, pp. 561-5.
Guigay, J, Temam, S, Bourhis, J, Pignon, JP, Armand, JP 2006, ‘Nasopharyngeal Carcinoma and Therapeutic Management: The Place of Chemotherapy’, Annals of Oncology, Vol. 17, no. 10, pp. 304 - 307.
Harahap, MPH 2009, Ekspresi Vascular Endothelial Growth Factor Pada
Karsinoma Nasofaring, Tesis. Fakultas Kedokteran Universitas sumatera utara, Medan. Harnoko, K, Jusuf, A, Hudoyo, A, & Prasetyo, S 2007, ‘Efektiviti Megestrol Asetat Untuk Pengobatan Anoreksia Dan Penurunan Berat Badan Penderita Kanker Paru Jenis Karsinoma Bukan Sel Kecil’, Departemen Indonesia, Vol 27 No.2 95-107.
Her, C 2001, ‘Nasopharyngeal Cancer and The Southeast Asian Patient’, American Family Physician, Vol. 63, no. 9, pp. 776 - 80.
Holzner, BG, Kemmler, R, Greil, M, Kopp, A, Zeimet, M, Raderer, M, Hejna, S, Zöchbauer, G, Krajnik, H, Huber, W, Fleischhacker & Unterweger, BS 2002, ‘The impact of hemoglobin levels on fatigue and quality of life in cancer patients’, Annals of Oncology, vol.13, pp.
965–73. Iskandar, M, Andrijono & Supriana, N 2008, ‘Uji klinik kemoradiasi dibanding radiasi terhadap respons infeksi HPV dan respons klinik pada karsinoma sel skuamos serviks uteri’, Maj. Obstetri Ginekol
Indonesia, vol. 32, no.4, pp. 212-22
Jeyakumar, A, Brickman, TM, Jeyakumar, A & Doerr, T 2006, ‘Review of Nasopharyngeal Carcinoma’, Ear, Nose and Throat Journal, Vol. 85, no. 3, pp. 168 - 184.
l,vol.18,no. 1, pp. 24-8.
Kaul, R, Verma, SC, Murakami, M, Lan, K, Choudhuri, T & Robertson, ES 2006, ‘Epstein-Barr Virus Protein Can Upregulate Cyclooxygenase-2
Expression Through Association with The Suppresor of Metastasis Nm23-H1’, Journal of Virology, Vol. 80, no. 3, pp. 1321 - 1331.
Nasofaring’, Fakultas Kedokteran Universitas Airlangga-RSUD Dr. Soetomo, Surabaya, Majalah Kedokteran Tropis Indonesia, vol. 14, no. 2. pp. 1-39.
Kyzas, PA, Stefanou, D & Agnantis, NJ 2005, ‘COX-2 Expression Correlates with VEGF-C and Lymph Node Metastases in Patients with Head and Neck Squamous Cell Carcinoma’, Modern Pathology, Vol.
18, pp. 153 - 60. Lamson, DW & Brignall, MS 1999, ‘Antioxidants in cancer therapy: their actions and interactions with oncologic therapies’, Alternative Medicine
Review, Vol. 4, no. 5, pp. 304 - 29.
Levita, J, Istyastono, EP, Nawawi, A, Mutholib, A, Esch, IJP & Ibrahim, S
‘
2009, Analyzing the Interaction of Andrographolide and Neoandrographolide, Diterpenoid Compounds From Andrographis Paniculata (Burm.F) nees, to Cyclooxygenase-2 Enzyme by Docking Simulation’, ITB J. Sci, Vol. 41 A, no. 2, pp. 110 - 19.
Lin, JC, Jan, JS, Hsu, CY, Liang WM, Jiang, RS & Wang, WY 2003, ‘Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival’, Journal of clinical oncology, vol. 21, no. 4, pp. 631-7.
Lo, AKF, Lo, KW, Tsao, SW, Wong, HL, Hui, JWY, To, KF, Hayward, SD, Chui, YL, Lau, YL, Takada, K & Huang DP 2006, ‘Epstain-Barr Virus
Infection Alters Cellular Signal Cascades in Human Nasopahryngeal Epithelial Cells’, Neoplasia, Vol. 8, no. 3, pp. 173 - 80.
Carcinoma’, Cancer Cell, Vol. 5, pp. 423 - 428. Loong, SLE, Hwang, JSG, Li, HH, Tien, J, Wee, S, Yap, SP, Chua, MLK,
Fong, KW & Tan, TWK 2009, ‘Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01)’ Radiation Oncology. Vol. 4, no. 23, pp. 1-7. Lutan, R 2003. ‘Diagnosis dan Penatalaksanaan Karsinoma Nasofaring’, Kumpulan Naskah KONAS XIII PERHATI, Bali, p.16.
Lutzky, VP, Moss, DJ, Chin, D, Coman, WB, Parsons, PG & Boyle, GM 2008, ‘Biomarkers for Cancers of The Head and Neck’, Clinical Medicine: Ear, Nose and Throat, Vol. 1, pp. 5 - 15.
Melani,W & Sofyan, F 2013, ‘Karakteristik Penderita Kanker Nasofaring di Rumah Sakit H. Adam Malik Medan tahun 2011’, E-Jurnal FK-USU, vol.1, no. 1.
Mohammadianpanah, M, Ghalael, SR, Shafizal, A, Tazlani, YA, Khademi,
B, Ansari, AM, Omildvari, S, Mosalael, A, Shirazi, MAM 2011, ‘Efficacy and safety of concurrent chemoradiation with weekly cisplatin ± low- dose celecoxib in locally advanced undifferentiated nasopharyngeal carcinoma’, Journal of Cancer Research and Therapeutik, vol. 7, no. 4, pp. 442-7. Mould, RF & Tai, THP 2002, ‘Nasopharyngeal Carcinoma: Treatments and Outcomes in the 20th century’, The British Journal of Radiology, Vol.
75, pp. 307 - 39. Moyer, P 2002, ‘Cyclooxygenase-2 Over-Expression Found in
Nasopharyngeal Carcinoma’, DG News, 25 September, viewed 27 Januari 2011,
Mulyarjo 2002, 'Diagnosis dan Penatalaksanaan Karsinoma Nasofaring, In Perkembangan Terkini Diagnosis dan Penatalaksanaan Tumor Ganas THT-KL’, FK-UNAIR, Surabaya, pp. 149-55.
Munir, D 2009, Karsinoma Nasofaring (kanker tenggorok), USU Press.
Medan. Murono, S, Inoue, H, Tanabe, T, Joab, I, Yoshizaki, T, Furukawa, M,
Pagano, JS 2001, ‘Induction of Cyclooxygenase-2 by Epstein-Barr Virus Latent Membrane Protein 1 is Involved in Vascular Endothelial Growth Factor Production in Nasopharyngeal Carcinoma Cells’, PNAS, Vol. 98, no. 12, pp. 6905 - 6910.
National Comprehensive Cancer Network (NCCN) 2010, Practice Guidelines in Oncology Head and Neck Cancers.
Puspasari, A 2010, Perbedaan Kadar Hemoglobin Pada Pasien
Karsinoma Nasofaring Sebelum dan setelah Radioterapi, Artikel Karya
Tulis Ilmiah. Program Pendidikan Sarjana Kedokteran Fakultas Kedokteran Universitas Diponegoro. Semarang. Puspitasari, D 2011, Gambaran penderita karsinoma nasofaring di RSUP
H. Adam Malik Medan tahun 2006-2010, Tesis, Fakultas Kedokteran Universitas sumatera utara, Medan.
Rasyid, A 2000, ‘Karsinoma nasofaring: penatalaksanaan radioterapi’,:
Majalah Kedokteran Nusantara, Fakultas Kedokteran Universitas sumatera utara, Medan, vol. XXXIII, no.1, pp. 52-8.
Rishikesh, MK & Sadhana, SS 2003, ‘Protaglandins and Cyclooxygenase: Their Probable Role in Cancer’, Indian Journal of Pharmacology, Vol.
35, pp. 3 - 12. Roberts, JR, Bueno, R & Sugarbaker, DJ 1999, ‘Multimodality treatment of malignant superior venal caval syndrome’, Chest, vol. 116, pp. 835-7.
Roezin, A & Adham, M 2009, Karsinoma nasofaring, Buku Ajar Ilmu Kesehatan Telinga Hidung Tenggorok Kepala & Leher, Edisi Keenam, FKUI, Jakarta, pp. 182-7
Sari, VA 2004, Korelasi Tingkat Ekspresi Cyclooxygenase-2 dan
Gambaran Angiogenesis pada Karsinoma Nasofaring Tak
Berdiferensiasi, Tesis, Program Pendidikan Dokter Spesialis IlmuPenyakit THT FKUI, Jakarta. Sheehan, KMK, Sheahan, DP, Donoghue, F, MacSweeney, RM, Conroy,
DJ, Fitzgerald & Murray, FE 1999, ‘The Relationship between cyclooxygenase-2 expression and colorectal cancer’, JAMA, vol. 282, no.13, pp. 1254-1257. Sinicrope, FA & Gill, S 2004, ‘Role of cyclooxygenase-2 in colorectal cancer’, Cancer and Metastasis Reviews, vol. 23, pp. 63-75. Soo, R, Putti, T, Tao, Q, Goh, BC, Lee, KH, Seng, LK, Tan, L, Hsieh, WS 2005, ‘Overexpression of Cyclooxygenase-2 in Nasopharyngeal Expression’, Arch Otolaryngol Head Neck Surg, Vol. 131, pp. 147 - 152.
Tan, KB & Putti, TC 2005, ‘Cyclooxygenase-2 Expression in Nasopharyngeal Carcinoma: Immunohistochemical Findings and Potential Implications’, Journal of Clinical Pathology, Vol. 58, pp. 535 - 538.
Tjokroprawiro, BA & Yusuf, N 2012, ‘Radiotherapy outcome in stage IIB cervical cancer patients who are resistant to neoadjuvant chemotherapy in dr. Soetomo 2006-2010’ Fakultas Kedokteran, Departemen Ilmu Kebidanan dan Penyakit Kandungan, Universitas Airlangga, Surabaya.
Uchida, N, Suda, T & Ishiguro, K 2013, ‘Effect of chemotherapy for a breast cancer’, Yonago Acta Medica, Vol. 56, pp. 51-56.
Vijayakumar, S & Hellman, S 1997, ‘Advances in radiation oncology’, Lancet , vol. 349 (suppl II), pp. 1-3.
Wei, WI 2006, Nasopharyngeal Cancer, In Bailey BJ, Johnson JT,
th
Newland SD (ed), Head and Neck Surgery Otolaryngology, Vol. 2, 4 edn, Lippincot Williams and Wilkins, Philadelphia.
Williams, CS, Mann, M & DuBios, RN 1999, ‘The role of cyclooxygenases in inflammation, cancer, and development’, Oncogene, vol.18, pp.
7908-7916. Wu, AWJ, Gu, FJ, Ji, FZ, Li, & Xu, GW 2003, ’Role of COX-2 Carcinogenesis of Colorectal Cancer and it’s Relationship with Tumor Biological Characteristic and Patients Prognosis’, World J.
Yeh, SA, Tang, Y, Lui, CC & Huang, EY 2006, ’Treatment outcomes of patient with AJcc stage IVC nasopharyngeal carcinoma: benefits of primary radiotherapy’,Japan Journal clinical Oncology, Vol. 36, no. 3, pp. 132 - 136.